Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.

Autor: Barnadas, A1 abarnadasm@santpau.cat, Gil, M2, González, S3, Tusquets, I4, Muñoz, M5, Arcusa, A6, Prieto, L7, Margelí-Vila, M8, Moreno, A9, González, S (AUTHOR), Muñoz, M (AUTHOR), Margelí-Vila, M (AUTHOR)
Zdroj: British Journal of Cancer. 2/10/2009, Vol. 100 Issue 3, p442-449. 8p. 5 Charts, 1 Graph.
Databáze: Academic Search Ultimate